← back to search

Yuji Wang

Pennsylvania State University · US
Area of research
Biomedical Engineering · Biomaterials
Research interest
Research interests include Brassinosteroid, Cell biology, Biology, Oryza sativa, Triple-negative breast cancer, and Cancer research.
h-index
citations
193
works
11
NIH funding
primary concept
email

Recent publications

A multifunctional self-assembled hydrogel with bactericidal activity and macrophage metabolic reprogramming for diabetic bone defect repair
Materials Today Bio 2025cited by 5position: middledoi
Canonical Wnt Pathway Enhanced Dental Pulp Mesenchymal Stem Cells‐Mediated Cementum Regeneration
Journal of Oral Rehabilitation 2025cited by 4position: middledoi
New structural scaffolds to enhance the metabolic stability of arginine-derived PAD4 inhibitors
Results in Chemistry 2025cited by 4position: middledoi
Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
Biomedicine & Pharmacotherapy 2024cited by 30position: lastdoi
Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy
Pharmaceutics 2024cited by 20position: lastdoi
Caffeic acid inhibits the tumorigenicity of triple-negative breast cancer cells through the FOXO1/FIS pathway
Biomedicine & Pharmacotherapy 2024cited by 19position: middledoi
Phylodynamics unveils invading and diffusing patterns of dengue virus serotype-1 in Guangdong, China from 1990 to 2019 under a global genotyping framework
Infectious Diseases of Poverty 2024cited by 15position: middledoi
Nanonitrator: novel enhancer of inorganic nitrate’s protective effects, predicated on swarm learning approach
Science Bulletin 2023cited by 28position: middledoi
<i>OsBAK2</i>/<i>OsSERK2</i> expression is repressed by OsBZR1 to modulate brassinosteroid response and grain length in rice
Journal of Experimental Botany 2023cited by 20position: middledoi
The combination of the HDAC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo
Pharmacological Research 2023cited by 15position: middledoi
Chitosan nanomedicine containing RGD peptide and PAD4 inhibitor based on phenyl boronate coupling inhibition of primary tumor growth and lung metastasis
Biomedicine & Pharmacotherapy 2023cited by 12position: lastdoi
The ruthenium complex assists in nuclear targeting and selective killing of tumor cells
Nanoscale 2023cited by 11position: lastdoi
Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy
Nanoscale 2022cited by 61position: middledoi
Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cells
Pharmaceutical Biology 2022cited by 28position: middledoi
Inhibition of Peptidyl Arginine Deiminase 4-Dependent Neutrophil Extracellular Trap Formation Reduces Angiotensin II-Induced Abdominal Aortic Aneurysm Rupture in Mice
Frontiers in Cardiovascular Medicine 2021cited by 37position: middledoi
qGL3/OsPPKL1 induces phosphorylation of 14-3-3 protein OsGF14b to inhibit OsBZR1 function in brassinosteroid signaling
PLANT PHYSIOLOGY 2021cited by 26position: middledoi
An Adenylate Kinase OsAK3 Involves Brassinosteroid Signaling and Grain Length in Rice (Oryza sativa L.)
Rice 2021cited by 19position: middledoi
The phosphoproteomic and interactomic landscape of qGL3/OsPPKL1‐mediated brassinosteroid signaling in rice
The Plant Journal 2021cited by 16position: middledoi
Visible light-induced antibacterial and osteogenic cell proliferation properties of hydrogenated TiO<sub>2</sub> nanotubes/Ti foil composite
Nanotechnology 2021cited by 11position: middledoi
&lt;p&gt;TAT-Modified Gold Nanoparticles Enhance the Antitumor Activity of PAD4 Inhibitors&lt;/p&gt;
International Journal of Nanomedicine 2020cited by 32position: lastdoi
Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA
International Journal of Nanomedicine 2018cited by 12position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yijiang Jia · Ministry of Education of the People's Republic of China5 papers (2022–2025)Ruqin Wang · Nanjing Agricultural University4 papers (2021–2023)Ji Huang · South China Agricultural University4 papers (2021–2023)Liujia Chan · Harbin Medical University4 papers (2022–2024)Jiaqi Zhang · Hubei University of Medicine4 papers (2021–2023)Hongsheng Zhang · Guangzhou University of Chinese Medicine4 papers (2021–2023)Huaying Du · Nanjing Agricultural University4 papers (2021–2023)Ayijiang Taledaohan · Ministry of Education of the People's Republic of China4 papers (2020–2025)Guang Zuan Cai · Nanjing Agricultural University4 papers (2021–2023)Xiuying Gao · Nanjing Agricultural University4 papers (2021–2023)Lichun Zhao · Guangxi University3 papers (2022–2024)Yuheng Pang · Harbin Medical University3 papers (2022–2024)Wei Wang · Beijing Institute of Technology3 papers (2020–2023)Di Zhu · Ministry of Education of the People's Republic of China3 papers (2021–2022)Jiawang Liu · University of Tennessee at Knoxville2 papers (2023–2025)Jianbo Li · Nanjing Agricultural University2 papers (2021–2023)Jianbo Li · Cleveland Clinic2 papers (2021–2021)Yanming Wang · Huaiyin Institute of Technology2 papers (2020–2024)Lei Hu · Ministry of Education of the People's Republic of China2 papers (2023–2025)Renbo Jia · Ministry of Education of the People's Republic of China2 papers (2023–2024)